VERU INC. Equity Securities, FV-NI
VERU INC. (VERU) had Equity Securities, FV-NI of $1.91 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:EquitySecuritiesFvNi · last filed 2026-08-10
- 2026-06-30: Equity Securities, FV-NI $1.91M.
- 2026-03-31: Equity Securities, FV-NI $3.17M.
- 2025-12-31: Equity Securities, FV-NI $2.41M.
- 2025-09-30: Equity Securities, FV-NI $2.53M.
| Period end | Equity Securities, FV-NI |
|---|---|
| 2026-06-30 | $1.91M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $3.17M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.41M 10-Q · filed 2026-02-11 |
| 2025-09-30 | $2.53M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $742.29K 10-K · filed 2025-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |